telabio.com (TELA) - Koefisien utang jangka dawa marang modal

TELA Bio, Inc. (TELA) automates implant production using CNC machines and AI-driven fiber control. The long-term financial leverage ratio demonstrates that the indicator stands at 0.00, linking borrowed funds to equity. Management is implementing innovative materials to displace synthetics, while the company gradually expands its general surgery device portfolio to reduce its narrow specialization in tissue reconstruction.

The long-term debt-to-equity ratio assesses financial stability by analyzing long-term liabilities relative to shareholders' equity. The dynamics of the long-term debt-to-net assets ratio allow for a real-time assessment of the credit load based on market quotes. This metric is calculated as the ratio of loans with a maturity of more than one year to the total value of capital. For TELA Bio, Inc. (TELA), this balance is critical when scaling OviTex biomimetic technologies. Debt control ensures the stable implementation of innovative implants into surgical practice.